Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by HuntNGatheron Dec 21, 2012 12:08pm
166 Views
Post# 20761515

RE: Shareholder Power Against Consolidation

RE: Shareholder Power Against Consolidation

Consolidation is a critical step for SSS.  Without it, we all take what is left of our marbles and go home.  Or more realistically, we all just cry about having no more marbles at all.

Your posting history seems to be more that of soap-box evangelist crying out against any sort of consolidation rather than someone who knows even one iota about the challenges that Stem Cell Therapeutics has faced over the past few years, the amount of money in the bank, the potential future growth of the company, or the limitations to that growth that are alleviated by making it possible to raise more capital.

David Allan made the purpose of the consolidation clear.   He has spoken of it in the past.   The  letter on the site stemcellthera.com is clear and makes sense.  It is not padding his wallet in any way.  It is the only way to rise above the micro-cap, few-penny stock, that we currently are in spite of all the interesting potential we have.

I appreciate that you are emotional about SelectCore but that business, and that scenario, has nothing to do with this scenario and any assertion to the contrary is pure fiction meant to confuse and enflame investors with fanciful examples.

It may not turn out great for SSS.... i really don't know for sure but I feel better than I have in 2.5 years.

I do doubt that it could get much worse than we are at now.  Dead is dead after all.  At least his option presents a chance for a longer and prosperous life.  If we just sit back and burn cash at 3 cents and have no ability to raise more because of the TSX-V rules, we are just doomed to run out the clock.

 

HnG

 

 

Bullboard Posts